C.M. Bidwell & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $341K | Sell |
|
|||||
|
2024
Q2 | $358K | Hold |
|
|||||
|
2024
Q1 | $307K | Sell |
|
|||||
|
2023
Q4 | $388K | Sell |
|
|||||
|
2023
Q3 | $423K | Sell |
|
|||||
|
2023
Q2 | $370K | Buy |
|
|||||
|
2023
Q1 | $96.8K | Sell |
|
|||||
|
2022
Q4 | $218K | Sell |
|
|||||
|
2022
Q3 | $227K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $6K | Sell |
|
|||||
|
2019
Q3 | $364K | Buy |
|
|||||
|
2019
Q2 | $353K | Sell |
|
|||||
|
2019
Q1 | $654K | Sell |
|
|||||
|
2018
Q4 | $977K | Buy |
|
|||||
|
2018
Q3 | $729K | Buy |
|
|||||
|
2018
Q2 | $384K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $4.4M | Hold |
|
|||||
|
2016
Q4 | $3.85M | Buy |
|